Pioneering the next era of discovery by integrating AI algorithms with robotics execution to reinvent how new medicines are designed. SAN FRANCISCO — Medra, the company developing the first platform for Physical AI Scientists, today announced a $52 million Series A financing led by Human Capital, with participation from existing investors Lux Capital, Neo, and […]
Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK — Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced today that it has received an up to $21M award to lead a […]
STATESVILLE, N.C. — Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announced its successful debt refinancing and the full repayment of its Seller Notes. On December 4, 2025, Kewaunee Scientific Corporation (the “Company” or “Kewaunee”) successfully repaid in full and ahead of […]
New technology captures the biological units of communication between cells at higher yield and quality, increasing their value in understanding, diagnosing, and treating SAN FRANCISCO — Hermes Biosciences, a life science tools company developing a benchtop, hands-off system for the isolation of extracellular vesicles (EVs), today announced it raised a Seed financing round to deliver […]
PeptiSystems, a life science company developing advanced manufacturing solutions for peptide and oligonucleotide-based therapeutics, has announced a significant growth investment from Rubicon Healthcare Partners. The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market. Uppsala, Sweden — Rubicon Healthcare Partners is a growth-oriented […]
Funding will accelerate commercialization of its breakthrough biomarker detection platform MUSE®. Oberkochen, Germany | ZEISS Group ZEISS Ventures participated in an oversubscribed financing round of CHF 6.3 million for arcoris bio, a Swiss start-up specializing in a platform technology aimed at enhancing biomolecule detection and imaging for spatial multiomics solutions. The funding round, co-led by […]
Spin-off positions Solstice to accelerate growth and unlock shareowner value as a leading pure-play specialty materials company Poised to benefit from strong and resilient secular trends across cooling, building solutions, advanced computing, energy, safety and healthcare Begins trading today on Nasdaq under the ticker symbol “SOLS” MORRIS PLAINS, N.J. — Solstice Advanced Materials (NASDAQ: SOLS), […]
Company Welcomes Dr. Chuck Mattera, former Chair and CEO of Coherent Corp as new Chairman ALEXANDRIA, VA – HyperSpectral, the world’s first AI-powered spectral intelligence company, today announced the close of a $7M Series A-2 capital raise. The round will fuel accelerated development, expand partnerships, and position the company for a Series B round in […]
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont. — Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 2R44HG013456-02 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.” Pharmacogenomics is expanding clinicians’ ability to deliver personalized medicine, enabling drug selection, dosage, efficacy, and safety to be tailored to each patient’s unique biological needs. […]
Funding enables company to scale its DNA synthesis services to meet accelerating demand and empower scientists to innovate across medicine, agriculture, and beyond EMERYVILLE, Calif. — Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today announced that it has closed $45.2 million and secured commitments for an additional $9.2 million as part of an […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
